Please note that some translations using Google Translate may not be accurately represented, and image captions and downloaded documents cannot be translated. Dana-Farber assumes no liability for inaccuracies that may result for using this third-party tool, which is for website translation and not clinical interactions. You may request a live medical interpreter for a discussion about your care.
Phillip Devlin, MD, FACR is Associate Professor of Radiation Oncology at Harvard Medical School and Chief of the Division of Brachytherapy in the Department of Radiation Oncology at the Dana-Farber/Brigham and Women’s Cancer Center. He earned his medical degree at the University of Virginia School of Medicine in 1991 and completed his residency in Radiation Oncology at the University of Pennsylvania in 1995, followed by a specialized fellowship in brachytherapy at Memorial Sloan-Kettering Cancer Center in 1996. Dr. Devlin joined the staff of Dana-Farber in 1997.In addition to lecturing extensively both nationally and internationally, Dr. Devlin established and directs the Harvard Medical School Annual Brachytherapy Review Course, has more than 50 published manuscripts and book chapters and is editor of the Lippincott, Williams and Wilkins’ text, Brachytherapy: Applications and Techniques. Dr. Devlin is currently on the Executive Committees of both the American Society for Radiation Oncology (ASTRO) and the Massachusetts Radiological Society. In 2008 he was named a Fellow of the American College of Radiology (FACR), and he is currently leading two funded studies as part of the ACR’s Quality Research in Radiation Oncology (QRRO) project.
Dr. Devlin studies genetic markers for oral cavity cancer.
Brigham and Women's Hospital75 Francis StreetASB1 L2Boston MA, 02115Get Directions